Cerebrolysin 60MG

Based on preclinical and experimental research, Cerebrolysin has demonstrated:

• Neuroprotection & Anti-Excitotoxicity: In models of ischemic reperfusion injury, Cerebrolysin reduces neuronal cell death by modulating cell-death proteins (e.g., JNK, caspase-3) and attenuating excitotoxic signaling through NMDA receptor pathways.

• Activation of Antioxidant Pathways: In ischemia models, it activates the Keap1/Nrf2 antioxidant signaling pathway, reducing oxidative stress and promoting neuronal survival.

• Neurotrophic Support: Cerebrolysin stimulates the expression of neurotrophic factors (e.g., BDNF, NGF) that support neurogenesis, synaptic plasticity, and brain repair.

• Cognitive Function & Recovery: It has been studied for enhancing memory, learning, and recovery after neurological injury (e.g., stroke, TBI) due to its ability to promote synaptic repair and neuronal survival.

• Anti-inflammatory and Immunomodulatory Effects: Research suggests Cerebrolysin may reduce neuroinflammation and modulate immune signaling in the brain.

• Seizure Model Neuroprotection: In a pilocarpine-induced seizure study, Cerebrolysin was shown to reduce hippocampal neuronal death and increase BDNF expression.

Research-Use Only Disclaimer

This formulation of Cerebrolysin (60 mg) is for laboratory and scientific research purposes only.
It is not approved for human use in many jurisdictions, and its usage should be limited to controlled preclinical or in vitro experiments.